October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
WCLC24 highlights by Jose F. Corona-Cruz
Sep 8, 2024, 15:30

WCLC24 highlights by Jose F. Corona-Cruz

The WCLC24 is taking place at the San Diego Convention Center from September 7 to 10, 2024.

The WCLC 24 is organised by the International Association for the Study of Lung Cancer (IASLC). This major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.

Jose F. Corona-Cruz, Thoracic Surgical Oncologist in the Thoracic Oncology Department at National Cancer Institute (INCan) Mexico, shared a few highlights from the conference.

Insights from the Communications Workshop

  • Know your audience and tailor your message accordingly.
  • Build collaborations and network to amplify your reach and impact.

Jose F. Corona-Cruz

Empoeering the patients vía Dusty Joy Donaldson

Advocacy organizations not only help amplify awareness but also play a critical role in driving funding and supporting research.

Engaging with them can offer invaluable perspectives and strengthen research efforts.

Empoeering the patients vía Dusty Joy Donaldson.

Jose F. Corona-Cruz

Wonderful closure from Charu Aggarwal on becoming a social media guru

  • Use social media for research dissemination, engagement, and networking
  • Build your presence and be consistent.
  • Track metrics beyond likes and stay professional, and above all—have fun!

Jose F. Corona-Cruz

The Communications Committee Workshop at WCLC24

The Communications Committee Workshop is just getting started at WCLC24!

Come join us and learn from top experts in the field on how to maximize your impact through social media. Don’t miss out!

Jose F. Corona-Cruz

Press briefing by Matthew Smeltzer

Press briefing this morning: 

Matthew Smeltzer showed that while 67% of pts now receive testing, up to 43% of clinicians treat without waiting for results and only 29% of respondents believe it’s crucial for early-stage LC. We need to close these gaps.

Jose F. Corona-Cruz

Ready for Day 2?

Don’t forget to take your flag, strike a pose, and show your support for WCLC24!

Jose F. Corona-Cruz

For more updates on WCLC24, visit oncodaily.com.